BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

258 related articles for article (PubMed ID: 4872039)

  • 1. [Immunologic deficiencies in malignant diseases of the lymphoma group and in multiple myeloma].
    Hartl W; Hayduk K
    Arch Klin Med; 1967 Nov; 214(1):54-69. PubMed ID: 4872039
    [No Abstract]   [Full Text] [Related]  

  • 2. [Current trends in therapy and prophylaxis of immunological disorders in malignant hemoreticulopathies].
    Berceanu S; Gociu M
    Stud Cercet Med Interna; 1969; 10(3):197-208. PubMed ID: 4186583
    [No Abstract]   [Full Text] [Related]  

  • 3. The investigation of the immunological reactivity of patients with haemoblastosis.
    Libánský J
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1965; 84(2):172-89. PubMed ID: 4161254
    [No Abstract]   [Full Text] [Related]  

  • 4. [Blastic lymphocyte transformation caused by phytohemagglutinin in patients with lymphoproliferative diseases].
    Mantovani G; Petrini MT; Tognella S; Grifoni V
    Boll Soc Ital Biol Sper; 1972 Jul; 48(14):381-5. PubMed ID: 4628299
    [No Abstract]   [Full Text] [Related]  

  • 5. Protein production. A possible unifying concept of reticuloendothelial disease.
    King FM
    Natl Cancer Inst Monogr; 1969 Aug; 32():313-4. PubMed ID: 4187008
    [No Abstract]   [Full Text] [Related]  

  • 6. [Immunological behavior of patients with malignant blood diseases].
    Luca N
    Stud Cercet Med Interna; 1973; 14(5):429-46. PubMed ID: 4202394
    [No Abstract]   [Full Text] [Related]  

  • 7. [Immunopathology in lymphatic systemic diseases].
    Huber H; Huber C; Michlmayr G
    Verh Dtsch Ges Inn Med; 1973; 79():159-67. PubMed ID: 4133402
    [No Abstract]   [Full Text] [Related]  

  • 8. [Culture of peripheral lymphocytes in chronic malignant lymphoadenopathies].
    Giraudo Conesa LC; Braun M; Bachmann AE; Pavlovsky A
    Prensa Med Argent; 1971 Aug; 58(23):1160-2. PubMed ID: 4940640
    [No Abstract]   [Full Text] [Related]  

  • 9. [Study of immunologic reactivity of the delayed (cellular) type in patients with hematoblastosis].
    Libansky J
    Nouv Rev Fr Hematol; 1968; 8(2):233-8. PubMed ID: 4232368
    [No Abstract]   [Full Text] [Related]  

  • 10. Monoclonal gammopathy in lymphoma.
    Alexanian R
    Arch Intern Med; 1975 Jan; 135(1):62-6. PubMed ID: 1089397
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Quantitative immunoglobulin determination in paraproteinemias, lymphogranulomatosis and lympho-reticulosarcomatosis].
    Patakfalvi A; Simon K; Horváth T; Böhm G
    Orv Hetil; 1971 Jan; 112(2):75-8. PubMed ID: 4924220
    [No Abstract]   [Full Text] [Related]  

  • 12. Examinations of the bactericidal properties of the serum against gram-positive microbes in patients suffering from leukaemia, malignant lymphoma, myeloma and myelofibrosis.
    Libánský J; Jezková Z
    Experientia; 1964 Mar; 20(3):124-7. PubMed ID: 5322537
    [No Abstract]   [Full Text] [Related]  

  • 13. [Immunological aspects of malignant lymphoproliferative diseases].
    Rivero I; Diumenjo M
    Rev Clin Esp; 1977 Mar; 144(6):403-9. PubMed ID: 140441
    [No Abstract]   [Full Text] [Related]  

  • 14. [Lymphomas and immunity].
    Kouvalainen K
    Duodecim; 1970; 86(16):886-94. PubMed ID: 4917099
    [No Abstract]   [Full Text] [Related]  

  • 15. [Immunoglobulin composition of the blood in hemolymphoblastosis].
    Medina F; Tognella S
    Folia Allergol (Roma); 1967; 14(6):447-52. PubMed ID: 4171226
    [No Abstract]   [Full Text] [Related]  

  • 16. [Reactivity of the lymphocytes of lymph nodes in cases of malignant lymphoma to plant agglutinin].
    Stramignoni A; Navone R; Meriggi E
    Boll Soc Ital Biol Sper; 1969 Feb; 45(3):194-6. PubMed ID: 4899663
    [No Abstract]   [Full Text] [Related]  

  • 17. [Pathogenesis of immunologic deficiency diseases associated with lymphoproliferative disorders].
    Ponzone A; Tarocco RP; Nicola P
    Minerva Pediatr; 1970 Dec; 22(51):2542-60. PubMed ID: 4993895
    [No Abstract]   [Full Text] [Related]  

  • 18. [Use of antilymphocyte globulin as a study method in the identification of lymphoid antigens expressed by populations of leukemic and/or lymphomatous cells].
    Marmont A
    Minerva Med; 1978 Apr; 69(18):1263-74. PubMed ID: 351459
    [No Abstract]   [Full Text] [Related]  

  • 19. [Study of immunoglobulin in malignant lymphoma].
    Isobe T; Kato T
    Saishin Igaku; 1968 Nov; 23(11):2454-9. PubMed ID: 4180058
    [No Abstract]   [Full Text] [Related]  

  • 20. [Significance of the HL-A-antigensystem in tumor research].
    Kuwert E; Bertrams J
    Z Krebsforsch Klin Onkol Cancer Res Clin Oncol; 1972; 78(2):204-18. PubMed ID: 4264844
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 13.